Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Journal of Visualized Experiments · 2023
DOI: 10.3791/64308 ↗Kurz gefasst
Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2023. Verfasst von Joo-Hui Han und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, St. Jude Children's Research Hospital. Hauptthemen laut MEDLINE: Apoptosis, Caspases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
Innate immunity provides the critical first line of defense in response to pathogens and sterile insults. A key mechanistic component of this response is the initiation of innate immune programmed cell death (PCD) to eliminate infected or damaged cells and propagate immune responses. However, excess PCD is associated with inflammation and pathology. Therefore, understanding the activation and regulation of PCD is a central aspect of characterizing innate immune responses and identifying new therapeutic targets across the disease spectrum. This protocol provides methods for characterizing innate immune PCD activation by monitoring caspases, a family of cysteine-dependent proteases that are often associated with diverse PCD pathways, including apoptosis, pyroptosis, necroptosis, and PANoptosis. Initial reports characterized caspase-2, caspase-8, caspase-9, and caspase-10 as initiator caspases and caspase-3, caspase-6, and caspase-7 as effector caspases in apoptosis, while later studies found the inflammatory caspases, caspase-1, caspase-4, caspase-5, and caspase-11, drive pyroptosis. It is now known that there is extensive crosstalk between the caspases and other innate immune and cell death molecules across the previously defined PCD pathways, identifying a key knowledge gap in the mechanistic understanding of innate immunity and PCD and leading to the characterization of PANoptosis. PANoptosis is a unique innate immune inflammatory PCD pathway regulated by PANoptosome complexes, which integrate components, including caspases, from other cell death pathways. Here, methods for assessing the activation of caspases in response to various stimuli are provided. These methods allow for the characterization of PCD pathways both in vitro and in vivo, as activated caspases undergo proteolytic cleavage that can be visualized by western blotting using optimal antibodies and blotting conditions. A protocol and western blotting workflow have been established that allow for the assessment of the activation of multiple caspases from the same cellular population, providing a comprehensive characterization of the PCD processes. This method can be applied across research areas in development, homeostasis, infection, inflammation, and cancer to evaluate PCD pathways throughout cellular processes in health and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, St. Jude Children's Research Hospital.
- Department of Immunology, St. Jude Children's Research Hospital; thirumala-devi.kanneganti@stjude.org.
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- NIAMS NIH HHS
Zitieren
APA
Han, J. H., Tweedell, R. E., & Kanneganti, T. D. (2023). Evaluation of Caspase Activation to Assess Innate Immune Cell Death. Journal of Visualized Experiments. https://doi.org/10.3791/64308
Vancouver
Han JH, Tweedell RE, Kanneganti TD. Evaluation of Caspase Activation to Assess Innate Immune Cell Death. Journal of Visualized Experiments. 2023. doi:10.3791/64308
BibTeX
@article{Han2023,
author = {Han, Joo-Hui and Tweedell, Rebecca E and Kanneganti, Thirumala-Devi},
title = {Evaluation of Caspase Activation to Assess Innate Immune Cell Death},
journal = {Journal of Visualized Experiments},
year = {2023},
doi = {10.3791/64308}
}
EUVIMED